Labcorp, a leading global life sciences company, and AtlantiCare, the largest health care organization in southern New Jersey, today announced that they have closed a transaction to expand their long-term strategic relationship. Labcorp will acquire select assets from AtlantiCare’s clinical outreach business, which serves the AtlantiCare Physician Group and Affiliated Physicians and their patients across southern New Jersey. The transaction is the latest in a series of new and expanded

908 Devices Inc., a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced updates to its MX908 handheld mass spec device, adding new capabilities to streamline workflows and improve field safety for first responders. The device will now include enhanced Bluetooth features with remote applications for iPhone mobile devices, as well as a broader range of drugs, including fentanyl analogs and synthetic opioids and cannabinoids.

Researchers at Children's Hospital of Philadelphia (CHOP) have developed a new tool to help researchers interpret the clinical significance of somatic mutations in cancer. The tool, known as CancerVar, incorporates machine learning frameworks to go beyond merely identifying somatic cancer mutations and interpret the potential significance of those mutations in terms of cancer diagnosis, prognosis, and targetability. A paper describing CancerVar was published today in Science Advances.

British surgical instrument manufacturer Surgical Holdings have announced the launch of a new company-wide green initiative to reduce both their and the NHS’s carbon footprint. This initiative includes launching a new Ethical Duty Smart Repair service, which actively promotes the repair and refurbishment of surgical instruments and other medical devices to tackle global steel wastage. Customers can now access a unique online customer dashboard, Surgifix, which allows

PatientPoint® today announced a new collaboration promoting online resources from the National Alliance on Mental Illness (NAMI) and the NAMI HelpLine in the offices of more than 140,000 physicians nationwide. As part of the new campaign, PatientPoint will promote NAMI on PatientPoint's Wait-Time Communication Platform, Interact Exam Room Platform and Provider Access Platform in both primary care and specialty practices. At least 2 in 5 adults in the U.S. reported having a m

National Spine and Pain Centers, the nation's leading network of minimally invasive spine and pain physicians, today announced the addition of Texas-based Dallas Pain Consultants (DPC) to its rapidly growing footprint. The move increases NSPC's presence to 18 locations in the Dallas-Fort Worth metroplex and results in a network of more than 130 locations in 13 states, which will facilitate 1.2 million patient visits this year. Studies estimate that 100 million Americans suff

NextGen Healthcare, Inc., a leading provider of innovative, cloud-based healthcare technology solutions, today announced a partnership with Circuit Clinical to bring clinical trial access to patients of Federally Qualified Health Centers (FQHCs) through over 14,000 providers that utilize NextGen Healthcare solutions. Historically, these underserved communities have not had easy access to participate in transformative clinical research that can provide enhanced treatment options. Such research

NanoVibronix, Inc., a medical device company that produces the UroShield® and PainShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has submitted a 510(k) application to the U.S. Food and Drug Administration (FDA) for its PainShield® MD PLUS, its dual-actuator ultrasound pain therapy device. Brian Murphy, CEO of NanoVibronix, stated, “This submission is an important step towards full commercialization of our product and

NeurOptics, the worldwide leader in the science of pupillometry, has expanded globally, launching its NPi®-300 in 15 international countries, including the U.K., France, Italy, Germany, Switzerland, Austria, Norway, Sweden, Denmark, Belgium, the Netherlands, Luxembourg, Ireland, Australia and New Zealand. The NPi-300 Pupillometer is an automated pupillometer that enhances pupillary assessment to assist in detecting cerebral insult, guiding treatment and informing prognosis for clinicians

Vivalink, a leading provider of digital healthcare solutions, announces availability of the world's first multi-vital blood pressure patch for remote patient monitoring for use in commercial research and development. The advanced multimodal continuous signal processing patch uses electrical signal-based technologies to capture ECG trace, heart rate, respiratory rate, systolic and diastolic blood pressure on a single device. The device is FDA/NMPA cleared for ECG and heart rate, and CE cle